Madiha Derouazi

Direttore Tecnico/Scientifico/R&S presso AC IMMUNE SA

Patrimonio netto: 12 668 $ in data 30/06/2024

51 anni

Health Technology

Consumer Services

Posizioni attive di Madiha Derouazi

Società	Posizione	Inizio	Fine
AC IMMUNE SA	Direttore Tecnico/Scientifico/R&S	01/01/2024	-
Amal Therapeutics SA Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.	Direttore/Membro del Consiglio	03/09/2012	-
	Amministratore Delegato	03/09/2012	-
	Fondatore	03/09/2012	-

Società	Posizione	Inizio	Fine

Technical University of Berlin	Graduate Degree
Swiss Federal Institute of Technology	Doctorate Degree

Distribuzione geografica

Svizzera	4
Germania	2

Posizioni

Settori

Health Technology	3
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
AC IMMUNE SA	Health Technology

Aziende private	1
Amal Therapeutics SA Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.	Health Technology

Aziende private

Health Technology